Innate Pharma Reports Updated Share Capital and Voting Rights as of July 3, 2025,Business Wire French Language News
Innate Pharma Reports Updated Share Capital and Voting Rights as of July 3, 2025 Marseille, France – July 4, 2025 – Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), a clinical-stage biotechnology company focused on discovering and developing therapeutic antibodies for oncology and inflammatory diseases, today announced the total number of its shares and voting … Read more